A detailed history of Comerica Securities,Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Comerica Securities,Inc. holds 16,108 shares of BMY stock, worth $948,277. This represents 0.08% of its overall portfolio holdings.

Number of Shares
16,108
Previous 16,121 0.08%
Holding current value
$948,277
Previous $1.03 Million 9.32%
% of portfolio
0.08%
Previous 0.07%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

SELL
$57.89 - $64.73 $752 - $841
-13 Reduced 0.08%
16,108 $934,000
Q2 2023

Aug 04, 2023

SELL
$63.71 - $70.74 $123,788 - $137,447
-1,943 Reduced 10.76%
16,121 $1.03 Million
Q1 2023

Apr 27, 2023

BUY
$65.71 - $74.53 $23,721 - $26,905
361 Added 2.04%
18,064 $1.25 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $102,993 - $121,959
1,504 Added 9.28%
17,703 $1.27 Million
Q3 2022

Nov 07, 2022

SELL
$0.13 - $76.84 $269 - $159,443
-2,075 Reduced 11.35%
16,199 $1.15 Million
Q2 2022

Jul 19, 2022

BUY
$72.62 - $79.98 $119,459 - $131,567
1,645 Added 9.89%
18,274 $1.42 Million
Q1 2022

Apr 28, 2022

BUY
$61.48 - $73.72 $363,162 - $435,464
5,907 Added 55.09%
16,629 $1.22 Million
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $811,314 - $945,802
-15,128 Reduced 58.52%
10,722 $669,000
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $86,802 - $101,677
1,467 Added 6.02%
25,850 $1.54 Million
Q2 2021

Aug 11, 2021

SELL
$61.91 - $67.42 $68,658 - $74,768
-1,109 Reduced 4.35%
24,383 $1.63 Million
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $147,222 - $165,581
-2,481 Reduced 8.87%
25,492 $1.62 Million
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $1,385 - $1,570
24 Added 0.09%
27,973 $1.75 Million
Q3 2020

Nov 04, 2020

BUY
$57.43 - $63.64 $58,521 - $64,849
1,019 Added 3.78%
27,949 $1.69 Million
Q2 2020

Jul 17, 2020

SELL
$54.82 - $64.09 $681,357 - $796,574
-12,429 Reduced 31.58%
26,930 $1.58 Million
Q1 2020

Apr 16, 2020

BUY
$46.4 - $67.43 $1.33 Million - $1.93 Million
28,603 Added 265.93%
39,359 $2.19 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $141,035 - $183,968
2,866 Added 36.32%
10,756 $690,000
Q3 2019

Oct 15, 2019

BUY
$42.77 - $50.71 $78,825 - $93,458
1,843 Added 30.48%
7,890 $400,000
Q3 2019

Oct 15, 2019

SELL
$42.77 - $50.71 $42,513 - $50,405
-994 Reduced 14.12%
6,047 $314,000
Q2 2019

Aug 09, 2019

BUY
$44.62 - $49.34 $31,189 - $34,488
699 Added 11.02%
7,041 $319,000
Q1 2019

May 07, 2019

BUY
$45.12 - $53.8 $286,151 - $341,199
6,342 New
6,342 $303,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Comerica Securities,Inc. Portfolio

Follow Comerica Securities,Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comerica Securities,Inc. with notifications on news.